Mr Sean James Johnson
Teams and roles for Sean James Johnson
Publication
2025
2024
- Randell, E. et al. 2024. Watch Me Play! A pilot feasibility study of a remotely- delivered intervention to promote mental health resilience
for children (aged 0-8) across UK early years and children's services.. Project Report.Foundations.
- Rodríguez-Arbolí, E. et al., 2024. Optimal prognostic threshold for measurable residual disease positivity by multiparameter flow cytometry in acute myeloid leukemia (AML) [Letter to the Editor]. Leukemia 38 (10)(10.1038/s41375-024-02378-5)
- O’Hara, J. T. et al., 2024. Transoral laser or robotic surgery outcomes for oropharyngeal carcinoma. JAMA Otolaryngology-Head and Neck Surgery 150 (11), pp.1002-1011. (10.1001/jamaoto.2024.3371)
- Othman, J. et al., 2024. Molecular, clinical and therapeutic determinants of outcome in NPM1 mutated AML. Blood 144 (7), pp.714-728. (10.1182/blood.2024024310)
- Othman, J. et al., 2024. Postinduction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission. Blood 143 (19), pp.1931-1936. (10.1182/blood.2023023096)
- Randell, E. et al. 2024. Watch Me Play!: protocol for a feasibility study of a remotely delivered intervention to promote mental health resilience for children (ages 0–8) across UK early years and children’s services. Pilot and Feasibility Studies 10 (1) 55. (10.1186/s40814-024-01491-7)
- Scior, K. et al., 2024. Digital adaptation of the Standing up for Myself intervention in young people and adults with intellectual disabilities: the STORM feasibility study. Project Report.[Online].National Institute for Health Research. Available at: https://doi.org/10.3310/NCBU6224.
2023
2022
- Loo, S. et al., 2022. Pre-transplant FLT3-ITD MRD assessed by high-sensitivity PCR-NGS determines post-transplant clinical outcome [Letter]. Blood 140 (22), pp.2407-2411. (10.1182/blood.2022016567)
- Döhner, K. et al., 2022. Analysis of patient-level data from 3 cooperative group trials confirms a survival advantage for NPM1m patients achieving MRD-negative CR after intensive induction. Blood 140 (S1), pp.6293-6294. (10.1182/blood-2022-159212)
- Tazi, Y. et al., 2022. Unified classification and risk-stratification in Acute Myeloid Leukemia. Nature Communications 13 (1) 4622. (10.1038/s41467-022-32103-8)
- Johnson, S. J. , Verster, J. C. and Alford, C. 2022. An on-premise study to investigate the effects of mixing alcohol with caffeinated beverages. Brain and Behavior 12 (3) e2445. (10.1002/brb3.2445)
- Johnson, S. J. , Verster, J. C. and Alford, C. 2022. A comparison between ecological momentary assessment and the adapted-quick drinking screen: alcohol mixed with energy drinks. Alcohol and Alcoholism agab086. (10.1093/alcalc/agab086)
2021
2020
Articles
- Nollett, C. et al. 2025. Discussing data: A UK-wide public consultation on the use of low fidelity synthetic data for research. International Journal of Population Data Science 10 (1) 32. (10.23889/ijpds.v10i1.2962)
- Döhner, K. et al., 2025. A pooled analysis of 3 large multicenter trials confirms a survival advantage for NPM1 mut AML in MRD neg remission after intensive induction. HemaSphere 9 (8) e70198. (10.1002/hem3.70198)
- Potter, N. et al., 2025. Molecular monitoring versus standard clinical care in younger adults with acute myeloid leukaemia: results from the UK NCRI AML17 and AML19 randomised, controlled, phase 3 trials. The Lancet Haematology 12 (5), pp.e346-e356. (10.1016/S2352-3026(25)00037-7)
- Brady, O. P. et al. 2025. Survival prediction in acute myeloid leukemia at distinct treatment time points: a performance comparison of random survival forest and Elastic-Net regularized Cox regression. JMIR Bioinformatics and Biotechnology (10.2196/75678)
- Rodríguez-Arbolí, E. et al., 2024. Optimal prognostic threshold for measurable residual disease positivity by multiparameter flow cytometry in acute myeloid leukemia (AML) [Letter to the Editor]. Leukemia 38 (10)(10.1038/s41375-024-02378-5)
- O’Hara, J. T. et al., 2024. Transoral laser or robotic surgery outcomes for oropharyngeal carcinoma. JAMA Otolaryngology-Head and Neck Surgery 150 (11), pp.1002-1011. (10.1001/jamaoto.2024.3371)
- Othman, J. et al., 2024. Molecular, clinical and therapeutic determinants of outcome in NPM1 mutated AML. Blood 144 (7), pp.714-728. (10.1182/blood.2024024310)
- Othman, J. et al., 2024. Postinduction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission. Blood 143 (19), pp.1931-1936. (10.1182/blood.2023023096)
- Randell, E. et al. 2024. Watch Me Play!: protocol for a feasibility study of a remotely delivered intervention to promote mental health resilience for children (ages 0–8) across UK early years and children’s services. Pilot and Feasibility Studies 10 (1) 55. (10.1186/s40814-024-01491-7)
- Potter, N. et al., 2023. P503: a randomised trial of molecular monitoring versus standard clinical care in younger adults with acute myeloid leukaemia: results from the UK NCRI AML17 and AML19 studies. HemaSphere 7 , pp.857-858. e345570d. (10.1097/01.hs9.0000968920.34557.0d)
- Richardson, L. et al., 2023. Standing up for Myself (STORM): Adapting and piloting a web-delivered psychosocial group intervention for people with intellectual disabilities. Research in Developmental Disabilities 137 104496. (10.1016/j.ridd.2023.104496)
- Kim, A. J. et al., 2023. Depression, anxiety, and stress among hangover-sensitive and hangover-resistant drinkers. Journal of Clinical Medicine 12 (8) 2766. (10.3390/jcm12082766)
- Loo, S. et al., 2022. Pre-transplant FLT3-ITD MRD assessed by high-sensitivity PCR-NGS determines post-transplant clinical outcome [Letter]. Blood 140 (22), pp.2407-2411. (10.1182/blood.2022016567)
- Döhner, K. et al., 2022. Analysis of patient-level data from 3 cooperative group trials confirms a survival advantage for NPM1m patients achieving MRD-negative CR after intensive induction. Blood 140 (S1), pp.6293-6294. (10.1182/blood-2022-159212)
- Tazi, Y. et al., 2022. Unified classification and risk-stratification in Acute Myeloid Leukemia. Nature Communications 13 (1) 4622. (10.1038/s41467-022-32103-8)
- Johnson, S. J. , Verster, J. C. and Alford, C. 2022. An on-premise study to investigate the effects of mixing alcohol with caffeinated beverages. Brain and Behavior 12 (3) e2445. (10.1002/brb3.2445)
- Johnson, S. J. , Verster, J. C. and Alford, C. 2022. A comparison between ecological momentary assessment and the adapted-quick drinking screen: alcohol mixed with energy drinks. Alcohol and Alcoholism agab086. (10.1093/alcalc/agab086)
- Benson, S. et al., 2021. A cross-cultural comparison of the effects of alcohol mixed with energy drink (AMED) consumption on overall alcohol consumption and related consequences. International Journal of Environmental Research and Public Health 18 (14) 7579. (10.3390/ijerph18147579)
- Johnson, S. J. et al. 2021. Risk-taking behavior and the consumption of alcohol mixed with energy drink among Australian, Dutch and UK students. International Journal of Environmental Research and Public Health 18 (10) 5315. (10.3390/ijerph18105315)
- Verster, J. C. et al., 2020. Sensitivity to experiencing alcohol hangovers: reconsideration of the 0.11% blood alcohol concentration (BAC) threshold for having a hangover. Journal of Clinical Medicine 9 (1) 179. (10.3390/jcm9010179)
Monographs